2017
DOI: 10.1590/0037-8682-0133-2017 View full text |Buy / Rent full text
|
|

Abstract: Introduction:The drugs available for visceral leishmaniasis (VL) treatment in Brazil have specific characteristics in terms of operability, effectiveness, toxicity, and cost. The aim of this study was to estimate the direct costs of therapies recommended by the Ministry of Health (MH) for VL treatment in Brazil. Methods: The analytical perspective used was that adopted by the Brazilian Public Health System. Three drugs and four regimens were included: 1) N-methyl glucamine antimoniate intramuscularly at 20mg p… Show more

Help me understand this report

Search citation statements

Order By: Relevance
0
0
0
0
0
1
9
0

Publication Types

Select...

Relationship

0
0

Authors

Journals